secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2024-11-14T23:59:59+00:00
Accession:  0001654954-24-014464
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision posts Q3 net loss $4.1M, revenue $96K; warrants raise $4.9M
------------------------------------------------------------------------------

- Sales revenue for Q3 2024 was ~$96K, net loss $4.1M (including $1.7M non-cash charges); nine-month net loss $11.0M.
- Cash at Sept 30 was $1.3M; on Oct 25, 2024, warrant exercise raised gross proceeds of $4.9M.
- Company has 87 hospitals in pipeline; 32 institutions in ongoing evaluations; CE Mark for LockeT expected by end of Q1 2025.
- Commercial team includes new CCO Marie-Claude Jaques; VIVO procedures ongoing in multiple European countries.
- Over 130 patients enrolled in LockeT II comparative study; initial LockeT study published in JCE in August.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424014464/0001654954-24-014464-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424014464/catheter_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-014464

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer